Direct-to-Consumer Marketing of Genetic Tests for Cancer: Buyer Beware

This publication has 20 references indexed in Scilit:

• Limitations of Direct-to-Consumer Advertising for Clinical Genetic Testing
  JAMA, 2002
• Direct-to-Consumer Advertising — Strengthening Our Health Care System
  New England Journal of Medicine, 2002
• Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation
  New England Journal of Medicine, 2001
• The Rise of Direct-to-Consumer Advertising of Prescription Drugs in the United States
  JAMA, 2000
• Avalanche of direct-to-consumer drug marketing brings new questions.
  JNCI Journal of the National Cancer Institute, 2000
• Direct-to-Consumer Prescription Drug Advertising Builds Bridges Between Patients and Physicians
  JAMA, 1999
• Population-based study of risk of breast cancer in carriers of BRCA2 mutation
  The Lancet, 1998
• Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
  American Journal of Human Genetics, 1998
• The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jews
  New England Journal of Medicine, 1997
• The genetic attributable risk of breast and ovarian cancer
  Cancer, 1996